PureTech Financial Statements From 2010 to 2025

PRTC Stock  USD 17.80  0.36  2.06%   
PureTech Health financial statements provide useful quarterly and yearly information to potential PureTech Health PLC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on PureTech Health financial statements helps investors assess PureTech Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting PureTech Health's valuation are summarized below:
Gross Profit
-81.5 M
Market Capitalization
427.5 M
Enterprise Value Revenue
348.8244
Revenue
468 K
Earnings Share
(3.00)
We have found one hundred twenty available trending fundamental ratios for PureTech Health PLC, which can be analyzed and compared to other ratios and to its competitors. Investors should ensure to check out all of PureTech Health's recent performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of March 18, 2025, Market Cap is expected to decline to about 665.7 M. In addition to that, Enterprise Value is expected to decline to about 524 M

PureTech Health Total Revenue

5.51 Million

Check PureTech Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PureTech Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7 M, Interest Expense of 16.3 M or Selling General Administrative of 26.9 M, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 2.0E-4 or PTB Ratio of 0.16. PureTech financial statements analysis is a perfect complement when working with PureTech Health Valuation or Volatility modules.
  
Check out the analysis of PureTech Health Correlation against competitors.

PureTech Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets544.9 M798.1 M457.9 M
Slightly volatile
Short and Long Term Debt Total26.1 M29.1 M21.4 M
Slightly volatile
Other Current Liabilities32.4 M34.1 M71.9 M
Slightly volatile
Total Current Liabilities56.1 M59.1 M118.4 M
Pretty Stable
Property Plant And Equipment Net19.9 M22.3 M16.4 M
Slightly volatile
Accounts Payable10.4 M16.8 MM
Slightly volatile
Cash180.3 M219.7 M149.3 M
Slightly volatile
Non Current Assets Total257.8 M398.8 M217.5 M
Slightly volatile
Non Currrent Assets Other960.3 KM93.5 M
Slightly volatile
Cash And Short Term Investments273.9 M376.2 M228.9 M
Slightly volatile
Common Stock Total Equity4.6 M4.9 M13.8 M
Pretty Stable
Common Stock Shares Outstanding333.6 M317.7 M126.7 M
Slightly volatile
Liabilities And Stockholders Equity544.9 M798.1 M457.9 M
Slightly volatile
Non Current Liabilities Total222.6 M212 M71.3 M
Slightly volatile
Other Current Assets11.1 M20.3 M9.7 M
Slightly volatile
Other Stockholder Equity279 M282.5 M229.5 M
Slightly volatile
Total Liabilities223.8 M271.1 M186.3 M
Slightly volatile
Property Plant And Equipment Gross24.3 M37.2 M20.5 M
Slightly volatile
Total Current Assets287.1 M399.3 M240.3 M
Slightly volatile
Short Term Debt9.8 M8.2 MM
Slightly volatile
Intangible Assets774.6 K815.4 K2.2 M
Slightly volatile
Common Stock4.7 M4.9 M13.8 M
Pretty Stable
Other Liabilities26 M27.3 M28.1 M
Slightly volatile
Net Tangible Assets490.8 M622.6 M363.9 M
Slightly volatile
Other Assets0.860.9369.3 K
Pretty Stable
Net Receivables3.7 M2.7 M2.1 M
Slightly volatile
Short and Long Term Debt3.2 M3.3 M7.4 M
Very volatile
Property Plant Equipment28 M50.5 M22.5 M
Slightly volatile
Net Invested Capital554.7 M537.9 M385.9 M
Slightly volatile
Capital Lease Obligations28.8 M24.9 M13.4 M
Slightly volatile
Capital StockM6.3 M5.5 M
Slightly volatile
Inventory1.091.152.2 M
Pretty Stable

PureTech Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And AmortizationM5.7 M5.7 M
Slightly volatile
Interest Expense16.3 M15.5 M4.2 M
Slightly volatile
Selling General Administrative26.9 M29 M22.3 M
Slightly volatile
Total Revenue5.5 MM6.7 M
Pretty Stable
Other Operating Expenses109.6 M172 M94.1 M
Slightly volatile
Research Development56.3 M110.7 M49.3 M
Slightly volatile
Total Operating Expenses109.3 M169 M93.7 M
Slightly volatile
Interest Income19.3 M18.4 M4.9 M
Slightly volatile
Reconciled Depreciation6.2 M5.7 M4.1 M
Slightly volatile
Selling And Marketing Expenses18.5 M20.9 M22.7 M
Slightly volatile

PureTech Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation9.9 M5.1 M7.7 M
Slightly volatile
Begin Period Cash Flow149.5 M172.3 M123.4 M
Slightly volatile
Depreciation3.9 M5.7 M3.4 M
Slightly volatile
Dividends Paid311.7 K451.9 K265.3 K
Slightly volatile
Capital Expenditures267.7 K281.8 K2.9 M
Very volatile
End Period Cash Flow165.9 M219.7 M138.6 M
Slightly volatile
Issuance Of Capital Stock985.8 KM89.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio19.9921.04184
Very volatile
Dividend Yield2.0E-41.0E-42.0E-4
Slightly volatile
Days Sales Outstanding341234282
Slightly volatile
Stock Based Compensation To Revenue1.131.192.4286
Pretty Stable
Capex To Depreciation0.05430.05711.6276
Slightly volatile
EV To Sales1571661.8 K
Very volatile
Payables Turnover0.370.394.6417
Pretty Stable
Sales General And Administrative To Revenue8.146.818.6247
Pretty Stable
Research And Ddevelopement To Revenue15.626.0117.2931
Slightly volatile
Capex To Revenue0.06290.06620.5989
Very volatile
Cash Per Share11.1910.662.9082
Slightly volatile
Days Payables Outstanding1.3 K1.2 K714
Slightly volatile
Intangibles To Total Assets0.00140.00150.0483
Slightly volatile
Current Ratio6.396.082.4281
Slightly volatile
Receivables Turnover1.531.6110.8097
Slightly volatile
Capex Per Share0.01860.01020.0173
Pretty Stable
Revenue Per Share0.150.140.0742
Very volatile
Interest Debt Per Share1.331.260.3269
Slightly volatile
Debt To Assets0.06660.0420.0617
Pretty Stable
Graham Number0.961.012.2192
Very volatile
Days Of Payables Outstanding1.3 K1.2 K714
Slightly volatile
Long Term Debt To Capitalization0.0130.01670.0091
Slightly volatile
Total Debt To Capitalization0.05660.05960.1802
Slightly volatile
Quick Ratio6.396.082.4278
Slightly volatile
Cash Ratio3.523.351.4628
Slightly volatile
Days Of Sales Outstanding341234282
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.251.151.2524
Slightly volatile
Fixed Asset Turnover0.190.22.2549
Slightly volatile
Debt Ratio0.06660.0420.0617
Pretty Stable
Price Sales Ratio19.9921.04184
Very volatile
Asset Turnover0.00520.00550.1128
Slightly volatile

PureTech Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap665.7 M700.8 M5.8 B
Very volatile
Enterprise Value524 M551.6 M5.7 B
Very volatile

PureTech Fundamental Market Drivers

Cash And Short Term Investments327.1 M

PureTech Upcoming Events

26th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About PureTech Health Financial Statements

PureTech Health stakeholders use historical fundamental indicators, such as PureTech Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although PureTech Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in PureTech Health's assets and liabilities are reflected in the revenues and expenses on PureTech Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PureTech Health PLC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-26.5 M-25.2 M
Total RevenueM5.5 M
Cost Of Revenue5.7 M5.4 M
Stock Based Compensation To Revenue 1.19  1.13 
Sales General And Administrative To Revenue 6.81  8.14 
Research And Ddevelopement To Revenue 26.01  15.60 
Capex To Revenue 0.07  0.06 
Revenue Per Share 0.14  0.15 
Ebit Per Revenue(50.49)(53.01)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:
Check out the analysis of PureTech Health Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.615
Earnings Share
(3.00)
Revenue Per Share
0.02
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.13)
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.